Edition:
India

Taro Pharmaceutical Industries Ltd (TARO.N)

TARO.N on New York Stock Exchange

100.13USD
20 Feb 2018
Change (% chg)

$-1.47 (-1.45%)
Prev Close
$101.60
Open
$100.85
Day's High
$100.85
Day's Low
$98.80
Volume
10,898
Avg. Vol
37,277
52-wk High
$128.25
52-wk Low
$93.59

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Dec 155.46 0.450
Sep 169.91 1.303
Jun 161.32 1.347
FY 2017 Mar '17 196.41 2.046
Dec 220.40 3.417
Sep 228.79 2.996
Jun 233.78 2.596
FY 2016 Mar '16 265.07 2.685
Dec 258.34 4.415
Sep 212.06 3.115
Jun 215.28 2.420
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Mar-18 1 792.49 792.49 792.49 838.96
Year Ending Mar-19 1 713.24 713.24 713.24 755.07
Earnings (per share)
Year Ending Mar-18 1 9.49 9.49 9.49 10.04
Year Ending Mar-19 1 7.99 7.99 7.99 8.31
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 11.65 31.10 32.90
P/E High - Last 5 Yrs. 13.63 40.92 45.97
P/E Low - Last 5 Yrs. 9.81 23.79 24.37
Beta 0.66 0.90 0.89
Price to Sales (TTM) 5.73 3.98 5.77
Price to Book (MRQ) 2.16 4.84 5.41
Price to Tangible Book (MRQ) 2.16 5.66 6.98
Price to Cash Flow (TTM) 11.11 23.02 23.42
% Owned Institutions 15.56 1.25 2.22

Dividends

  Company industry sector
Dividend Yield -- 1.57 1.50
Dividend Yield - 5 Year Avg -- 1.58 1.52
Dividend 5 Year Growth Rate -- 4.33 5.21
Payout Ratio(TTM) 0.00 45.86 43.72

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -31.00 3.67 9.24
Sales (TTM) vs TTM 1 Yr. Ago -16.75 4.72 5.59
Sales - 5 Yr. Growth Rate -- 10.02 10.27
EPS (MRQ) vs Qtr. 1 Yr. Ago -48.11 16.64 19.65
EPS (TTM) vs TTM 1 Yr. Ago -23.45 -- --
EPS - 5 Yr. Growth Rate -- 9.82 10.73
Capital Spending - 5 Yr. Growth Rate -- 15.22 15.19

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 8.70 2.11 2.18
Current Ratio (MRQ) 9.40 2.89 2.97
LT Debt to Equity (MRQ) 0.00 9.91 12.22
Total Debt to Equity (MRQ) 0.00 13.93 16.52
Interest Coverage (TTM) -- 36.27 33.13

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 75.00 55.11 54.70
Gross Margin - 5 Yr. Avg. 77.70 52.40 52.42
EBITD Margin (TTM) 57.63 -- --
EBITD - 5 Yr. Avg 61.37 18.51 10.86
Operating Margin (TTM) 55.76 14.36 4.64
Operating Margin - 5 Yr. Avg. 58.59 14.42 6.26
Pre-Tax Margin (TTM) 60.10 14.77 5.44
Pre-Tax Margin - 5 Yr. Avg. 62.06 14.73 6.60
Net Profit Margin (TTM) 49.77 11.05 1.76
Net Profit Margin - 5 Yr. Avg. 51.25 11.07 2.91
Effective Tax Rate (TTM) 17.18 23.16 23.04
Effective Tax Rate - 5 Yr. Avg. 17.42 23.41 23.96

Efficiency

  Company industry sector
Revenue/Employee (TTM) 571,072 948,737,542 855,667,832
Net Income/Employee (TTM) 284,237 111,622,076 100,655,557
Receivable Turnover (TTM) 3.39 5.62 5.78
Inventory Turnover (TTM) 1.38 2.58 3.35
Asset Turnover (TTM) 0.36 0.95 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) 17.75 11.45 10.98
Return on Assets - 5 Yr. Avg. 26.79 12.98 12.37
Return on Investment (TTM) 19.76 14.90 14.43
Return on Investment - 5 Yr. Avg. 31.74 16.98 16.18
Return on Equity (TTM) 19.80 16.41 16.13
Return on Equity - 5 Yr. Avg. 32.04 18.08 17.47
  1 Year 3 Year 5 Year
Sales % -7.51 5.02 --
EPS (TTM) % -12.48 10.72 --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Taro Pharmaceutical Industries Ltd

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 8.81 5.06 99 25
13 Week -0.63 -5.47 99 35
26 Week -2.41 -9.83 99 30
52 Week 6.26 -9.93 99 12
YTD 8.48 -4.73 99 25
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 12.78%
# of Holders: 220
Total Shares Held: 5,124,339
3 Mo. Net Change: -844,849
# New Positions: 40
# Closed Positions: 64
# Increased Positions: 76
# Reduced Positions: 127
# Net Buyers: -51
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.